stockrow
Friday 6 November 2026
Export ITGR’s income statement to Excel — free account
Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
126.56
0.19
−0.15%
Follow ITGR
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 7 | 6 |
+8 more TTM periods Free account |
| 5.97% | 7.50% | 8.58% | 6.11% | ||
| 3.05% | 3.78% | 4.23% | 3.17% | ||
ROIC |
3.16% | 3.74% | 4.25% | 4.70% | |
Return on Tangible Assets |
9.13% | 11.40% | 12.87% | 9.57% | |
Average Days of Receivables |
69.00 | 67.07 | 64.47 | 68.15 | |
Free Cash Flow per Share |
2.40 | 3.29 | 2.91 | 3.03 | |
Free Cash Flow |
81.82 | 111.98 | 99.85 | 105.12 | |
Capital Expenditures |
(94.66) | (93.46) | (89.72) | (91.03) | |
| Other line items | |||||
Cash ROIC |
2.72% | 3.70% | 3.32% | 3.53% | |
Accounts Receivable Turnover |
5.57 | 5.75 | 6.15 | 6.27 | |
Accounts Payable Turnover |
12.42 | 11.95 | 12.04 | 12.61 | |
Inventory Turnover |
5.08 | 4.94 | 5.02 | 5.40 | |
Average Days of Payables |
29.43 | 29.80 | 30.73 | 30.51 | |
Days of Inventory on Hand |
73.87 | 76.75 | 76.00 | 68.44 | |
Tax Rate |
(0.04) | (0.06) | (0.11) | (0.18) | |
Research and Development Expense of Revenue |
2.80% | 2.64% | 2.78% | 2.67% | |
Selling, General and Administrative Expense of Revenue |
12.48% | 12.16% | 11.82% | 11.42% | |
Share Based Compensation of Revenue |
1.26% | 1.23% | 1.24% | 1.25% | |
Interest Coverage |
3.87 | 4.64 | 5.34 | 5.12 | |
Operating CF/Net income |
1.70 | 1.60 | 1.34 | 1.91 | |
Depreciation/Fixed assets |
0.27 | 0.27 | 0.27 | 0.26 | |
Capex/Depreciation |
(0.65) | (0.65) | (0.63) | (0.66) | |
Revenue per Share |
53.65 | 54.20 | 54.14 | 53.37 | |
Operating CF per Share |
5.19 | 6.04 | 5.53 | 5.65 | |
Capex per Share |
(2.78) | (2.75) | (2.62) | (2.62) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 |
Columns are period end dates · fundamentals updated 2 Nov 2026